Methods of Economic Evaluation for the German Statutory Healthcare System Hengjin Dong Editorial 17 September 2012 Pages: 1 - 4
The Applicability and Generalizability of Findings from Clinical Trials for Health-Policy Decisions Nick FreemantleFranz Hessel Current Opinion 17 September 2012 Pages: 5 - 10
Is Medication Review by Primary-Care Pharmacists for Older People Cost Effective? Arnold G. ZermanskyJonathan Silcock Review Article 17 September 2012 Pages: 11 - 24
Statin Therapy in Rheumatoid Arthritis Nick BansbackRoberta AraHyon K. Choi Original Research Article 17 September 2012 Pages: 25 - 37
Treating Relapsing Multiple Sclerosis with Subcutaneous versus Intramuscular Interferon-Beta-1a Shien GuoDuygu BozkayaDennis M. Meletiche Original Research Article 17 September 2012 Pages: 39 - 53
Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin’s Lymphoma Philippe FagnoniNoel MilpiedMarie-Christine Woronoff-Lemsi Original Research Article 17 September 2012 Pages: 55 - 68
Comparing the Cost Effectiveness of Risperidone and Olanzapine in the Treatment of Schizophrenia Using the Net-Benefit Regression Approach Annemieke De RidderDiana De Graeve Original Research Article 17 September 2012 Pages: 69 - 80
Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data Ulf-G GerdthamPhilip ClarkeSoffia Gudbjornsdottir Original Research Article 17 September 2012 Pages: 81 - 90